January 10, 2020 / 12:31 PM / 12 days ago

BRIEF-Codexis And Nestlé Health Science Sign Development Deal

Jan 10 (Reuters) - Codexis Inc:

* CODEXIS AND NESTLÉ HEALTH SCIENCE SIGN DEVELOPMENT AGREEMENT TO ADVANCE THERAPEUTIC CANDIDATE TOWARDS CLINICAL STUDIES AND EXTEND STRATEGIC COLLABORATION AGREEMENT

* CODEXIS INC - NEW DEAL WITH NESTLÉ WILL ADVANCE DEVELOPMENT OF CDX-7108, LEAD CANDIDATE FOR A POTENTIAL TREATMENT OF A GI DISORDER

* CODEXIS INC - ORIGINAL SCA WITH NESTLÉ WILL BE EXTENDED THROUGH END OF 2021 TO SUPPORT DISCOVERY OF THERAPEUTIC CANDIDATES FOR ADDITIONAL DISORDERS

* CODEXIS INC - CO, NESTLÉ HEALTH SCIENCE WILL RETAIN JOINT OWNERSHIP OVER RIGHTS TO CDX-7108 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below